The Mark Foundation for Cancer Research – Drug Discovery Award
Event details
| Date | 11.11.2024 |
| Category | Call for proposal |
Aim: The Mark Foundation for Cancer Research is dedicated to accelerating exciting academic discoveries into new therapies and platforms that will substantially improve outcomes for cancer patients. Currently, there are few options for academic scientists to obtain the resources and know-how to advance drug discovery efforts for promising new cancer targets.
To stem this gap, The Mark Foundation has established the Drug Discovery Award program. Through this program, The Mark Foundation aligns with investigators working to discover and progress a new therapeutic agent into preclinical development, providing not only resources to support post-target validation through early lead development but also the expertise of seasoned biopharma R&D scientists who will advise on activities on the critical path to developing a new therapeutic agent.
Eligible therapeutic modalities:
Duration: 1-3 years
Eligibility: Principal investigators must hold an MD, PhD, or equivalent and be independent researchers at their respective non-profit institutions.
How to Apply: PIs should submit a Project Concept Letter on the foundation’s online platform here. The Project Concept Letter can be a maximum of 2 pages, including any figures or tables. References may be included on an additional page. Full requirements here.
Deadline for Project Concept Letter: 11 November 2024
Further information
To stem this gap, The Mark Foundation has established the Drug Discovery Award program. Through this program, The Mark Foundation aligns with investigators working to discover and progress a new therapeutic agent into preclinical development, providing not only resources to support post-target validation through early lead development but also the expertise of seasoned biopharma R&D scientists who will advise on activities on the critical path to developing a new therapeutic agent.
Eligible therapeutic modalities:
- Large molecules / biologics
- Small molecules (including heterobifunctionals)
- Peptides
- Conjugates (ADC, radioconjugates)
- Nucleic acids (ASO, RNA)
- Lead discovery – generate and credential new leads against a validated target
- Optimization – assess and enhance efficacy, safety, and DMPK of existing leads
Duration: 1-3 years
Eligibility: Principal investigators must hold an MD, PhD, or equivalent and be independent researchers at their respective non-profit institutions.
How to Apply: PIs should submit a Project Concept Letter on the foundation’s online platform here. The Project Concept Letter can be a maximum of 2 pages, including any figures or tables. References may be included on an additional page. Full requirements here.
Deadline for Project Concept Letter: 11 November 2024
Further information
- More information about the program is available here
- A webinar will take place on 10 October 2024
- The application portal can be found here
- For any other questions, please contact the Research Office
Practical information
- General public
- Free